Endocrine Disorders

Disease State Hub

Q&As

Expert Q&A

GLP-1 Agonists and SGLT-2 Inhibitors for Patients With Diabetes

11/21/2022

In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.

11/21/2022

Research Summaries

Non-Diabetic Kidney Disease

Non-Diabetic Kidney Disease Prevalent in Individuals With Type 2 Diabetes

01/06/2023

Researchers found a high prevalence of kidney disease in patients with type 2 diabetes mellitus from causes other than diabetes.

01/06/2023

Endocrine disorders

Guidelines: The Pediatric Endocrine Society Publish Guidelines for Growth Hormone Deficiency in Children

09/09/2021

These recommendations come as an update to the 2003 guidelines after an extensive literature review process.

09/09/2021

Endocrine disorders

Endocrine Society: Guidelines For Diagnosis of Endocrine Disorders in Childhood Cancer Survivors

07/03/2018

The Endocrine Society has released a new clinical practice guideline on the diagnosis and treatment of hypothalamic-pituitary and growth disorders in survivors of childhood cancer.

07/03/2018

Endocrine disorders

Bone mineral density declines after cessation of growth hormone treatment

07/28/2017

Bone mineral density increases during long-term growth hormone treatment but decreases after cessation of treatment in young adults born small for gestational age, researchers from The Netherlands report. ...

07/28/2017

October 2024

Current Issue

October 2024

Volume 64

Issue 9